Vinay Gupta, MD
Critical Care Medicine · Seattle, WANPI 1003105917
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $130,096 of the $184,747 with a category attached, or 70.4%. Mesa Biotech, Inc. accounts for 68.8% of it on its own, with 4 other manufacturers making up the rest. Reporting peaked in 2022 at $62,706 and has fallen 69.8% since, to $18,950 in 2025. Among critical care medicine clinicians in WA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 14 payments — averaging $13,196 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Mesa Biotech, Inc.$127K
- Mckesson Corporation$54K
- Regeneron$2K
- Verathon Inc.$1K
- Pfizer$700
What the payments were for
- Consulting fees$130,09670%
- Speaking & faculty fees$53,70029%
- Travel & lodging$9501%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Mesa Biotech, Inc. | 3 | $127,090 |
| Mckesson Corporation | 7 | $53,950 |
| Regeneron | 1 | $2,006 |
| Verathon Inc. | 2 | $1,000 |
| Pfizer | 1 | $700 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Accula RT-PCR SARS-CoV-2 dock and assay$127,090
- HYDRA TEST$500
- BFLEX$500
How this compares
$184,747 in reported general payments places this provider in the 95th percentile of 115 critical care medicine providers in Washington.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other critical care medicine in Seattle
- Sara NikravanSeattle$106K
- Michael SouterSeattle$20K
- Oliver McElvaneySeattle$7K
- Sharukh LokhandwalaSeattle$7K
- Raquel BartzSeattle$5K
- Nicholas MarkSeattle$4K
- David AuSeattle$4K
- Pingping SongSeattle$2K
- Rahul SharmaSeattle$1K
- Andrew LimSeattle$936
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.